WO1998043652A1 - Boron carbohydrate complexes and uses thereof - Google Patents

Boron carbohydrate complexes and uses thereof Download PDF

Info

Publication number
WO1998043652A1
WO1998043652A1 PCT/US1998/006050 US9806050W WO9843652A1 WO 1998043652 A1 WO1998043652 A1 WO 1998043652A1 US 9806050 W US9806050 W US 9806050W WO 9843652 A1 WO9843652 A1 WO 9843652A1
Authority
WO
WIPO (PCT)
Prior art keywords
boron
supplement
carbohydrate
food
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/006050
Other languages
English (en)
French (fr)
Inventor
Dusan Miljkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP54182798A priority Critical patent/JP2001518882A/ja
Priority to DE69811508T priority patent/DE69811508T2/de
Priority to EP98913189A priority patent/EP1001788B1/en
Priority to AU67800/98A priority patent/AU6780098A/en
Publication of WO1998043652A1 publication Critical patent/WO1998043652A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/325—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the field of the invention is dietary boron.
  • boron is essential for the structure and function of cell walls, and may also be important in regulating hormones. In many animals, boron apparently also plays an important role, especially in calcium and magnesium metabolism. In chickens, for example, boron deficiency leads to poor growth and leg abnormalities in chicks, while boron supplementation produces 5 stronger egg shells. (Mastromatto E., et al., "Summary: International Symposium on the Health Effects of Boron and its Compounds", Environ Health Perspect., 1994 Nov.; 102, 7: 139-41).
  • boron is marketed as calcium borogluconate (Now Foods, Glendale Hts., Ill), and as boron citrate, aspartame and glycinate chelates (Twin Laboratories, Inc., Ronkonkoma, NY).
  • boron supplementation leave something to be desired.
  • the known forms either contain or are readily hydrolyzed in the gut to boric acid. Boric acid is reactive, and tends to accumulate in tissues other than bone or joint.
  • the amount of boron made available by known supplementation is extremely high compared with normal blood values.
  • a typical boron supplement, for example, may make almost 3 mg of elemental boron available to the tissues within a half hour after ingestion, which is about 14 times the normal total blood boron of 213 ⁇ g. (Hunt, CD., et al., "RDA Workshop: New Approaches, Endpoints and Paradigms for RDAs of Mineral Elements", American Institute of Nutrition, 1996, pp 2441 S - 245 IS).
  • complexes of boron with sugars and/or sugar alcohols are utilized as nutritional supplements, with the carbohydrate portion being selected to provide a boron-sugar association constant of at least 250, and preferably 500 or more.
  • boron is complexed with a saccharide having co- planar cis-OH groups capable of forming five or six membered rings through ester bonding with boric acid.
  • Such complexes may advantageously comprise fructose, mannose, xylose or sorbose.
  • the boron supplement can be included in a food.
  • a food Essentially the entire gamut of foods are contemplated, including both solid and liquid foods, staples and snacks, and highly processed and minimally processed foods.
  • Particularly preferred foods are magnesium containing foods, and especially magnesium containing snack foods such as those containing chocolate and/or nuts.
  • Figure 1 is a schematic showing three contemplated structures I, II and III according to one aspect of the present invention, wherein Me n+ comprises a metal ion having a valence of n+.
  • the present invention contemplates the use of sugar-boron complexes as nutritional supplements. Since boron may be best handled by the body in small doses spread throughout the day, it is preferred that such boron supplements would be included in foods, and especially in foods such as snacks which may be consumed throughout the day. While not limiting the class to particular types of snacks, it is contemplated that boron supplements according to the present invention may be included in solid snacks such as candies, cookies, crackers and chips, and also in beverages including soft drinks, juices, milk, liquor, beer wine and other spirits. Liquids in general may, in fact, be particularly desirable carriers for boron supplements because they may facilitate distribution of the supplement.
  • boron supplements according to the present invention may advantageously be included in staple foods such as cereals or rice, and other foods such as pet foods, TV dinners and so forth.
  • staple foods such as cereals or rice
  • other foods such as pet foods, TV dinners and so forth.
  • the term "included in” is intended to broadly encompass situations in which the boron supplement is added to the food before, during or after other processing, and where the supplement is added using whatever means is available.
  • preferred boron supplemented foods may also contain relatively high amounts of magnesium.
  • Particularly high magnesium containing foods are nuts, especially almonds (over 350 mg oz), and chocolate (over 80 mg/oz.).
  • sugar-boron supplements may advantageously be added to chocolate and chocolate nut bars, chocolate syrups, and so-called "breakfast bars” or “snack bars” at up to 3 mg of boron per serving.
  • Other preferred foods are those containing at least 25 mg/oz of magnesium, and more preferably at least 50 mg/oz of magnesium.
  • the D-Glucose can be almost completely regenerated from the mother liquor.
  • the crystalline fructose complex may then be purified further by recrystalization, or by other suitable means.
  • the final product will be present as an equilibrium of several different forms. It is contemplated, for example, that a fructoborate such as calcium fructoborate will be present in at least the three forms depicted in Figure 1, with the equilibrium concentration of II being much greater than III, which in turn is greater than I.
  • the solvent may comprise water, ethanol, acetone or any other appropriate, and preferably amphiphilic solvent.
  • the starting sugar mixture may comprise any sugar or combination of sugars. Suitable sugars for the reaction thus include mono- di-, tri-, oligo- or poly-saccharides, and may range from small three carbon sugars to the larger pentoses, hexoses and so forth. It is still further contemplated that calcium carbonate can be replaced or supplemented with another metal carbonates, such as Mg carbonate.
  • boric acid compounds of sorbose, sorbulose, sorbitol, and xylose, xylulose, and xylitol are all contemplated
  • one or both forms may be suitable, depending upon the sugar.
  • the distinction is somewhat moot in any event, because one form or the other greatly predominates in any solution.
  • the boron contemplated to be used herein may predominantly comprise any mixture of the two naturally occurring forms of boron, namely 10 B and ' ⁇ . In nature, these elements are present in about a 4: 1 ratio, and it is contemplated that the ratio of boron in preferred supplements herein will have substantially the same ratio.
  • sugar acids such as gluconic acid would not be particularly suitable because of their unfavorable configurations and consequently low association constants.
  • sugar acids such as gluconic acid
  • sucrose and “sugar alcohols” are contemplated herein to exclude sugar acids. These terms also exclude amino acids and other polyhydroxy acids such as citric acid and malic acid.
  • sugar-boron compounds may be included in pharmaceutical preparations either as an active ingredient or an adjunct.
  • Such preparations may be administered in any acceptable route, including per os, sublingually, by injection or intravenous infusion, nasally, by suppository, transcutaneously, and so forth, with suitable excipients, binders, carriers and other compounds included as known in the pharmaceutical arts. Dosage of such preparations is contemplated to provide between about 0.01 mg day/dose to about 10 mg/day/dose or more of boron.
  • acetone (99%, p. a. quality; 20 ml) is added to the reaction mixture, whereupon a colorless oil separates at the bottom of the reaction vessel.
  • Two layers are separated using a separatory funnel, and the lower layer (crude boron complex) is treated again with acetone (20 MI).
  • the mixture is triturated using a glass rod to induce crystallization, and the oil slowly solidifies. This produces a white crystalline solid.
  • the solid is filtered off on a Buchner funnel, washed with additional acetone, and air dried. The solid is then further dried in a vacuum oven at room temperature, leaving a solvent free, very pure Ca- fructoborate.
  • the yield is 2.05 g (75%).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
PCT/US1998/006050 1997-03-31 1998-03-26 Boron carbohydrate complexes and uses thereof Ceased WO1998043652A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP54182798A JP2001518882A (ja) 1997-03-31 1998-03-26 ホウ素炭水化物錯体及びこれらの使用
DE69811508T DE69811508T2 (de) 1997-03-31 1998-03-26 Bor-kohlenhydrat-komplexe und deren verwendungen
EP98913189A EP1001788B1 (en) 1997-03-31 1998-03-26 Boron carbohydrate complexes and uses thereof
AU67800/98A AU6780098A (en) 1997-03-31 1998-03-26 Boron carbohydrate complexes and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4288397P 1997-03-31 1997-03-31
US60/042,883 1997-03-31
US09/045,141 US5962049A (en) 1997-03-31 1998-03-20 Boron carbohydrate complexes and uses thereof
US09/045,141 1998-03-20

Publications (1)

Publication Number Publication Date
WO1998043652A1 true WO1998043652A1 (en) 1998-10-08

Family

ID=26719729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/006050 Ceased WO1998043652A1 (en) 1997-03-31 1998-03-26 Boron carbohydrate complexes and uses thereof

Country Status (7)

Country Link
US (1) US5962049A (cg-RX-API-DMAC10.html)
EP (1) EP1001788B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001518882A (cg-RX-API-DMAC10.html)
AU (1) AU6780098A (cg-RX-API-DMAC10.html)
DE (1) DE69811508T2 (cg-RX-API-DMAC10.html)
ES (1) ES2191291T3 (cg-RX-API-DMAC10.html)
WO (1) WO1998043652A1 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005509661A (ja) * 2001-11-20 2005-04-14 ザ プロクター アンド ギャンブル カンパニー 規定のホウ素化合物を含む組成物及びキット、それらの調製方法、並びにそれらの使用及び投与
LU92551B1 (fr) * 2014-08-29 2016-03-01 Vdf Futureceuticals Inc Compositions et procédés améliorés pour complexes de borocarbohydrate
EP2990058A1 (en) 2014-08-29 2016-03-02 VDF Futureceuticals, Inc. Improved compositions and methods for fructoborate complexes

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026665A1 (en) * 1999-10-15 2001-04-19 Bawa Rajan S Liquid nutritional supplement composition and method of preparation
EP1233772A4 (en) * 1999-11-19 2004-06-16 Topgene Inc Boron compounds and complexes as anti-inflammatories
US20020077354A1 (en) * 2000-10-05 2002-06-20 Dusan Miljkovic Methods and compositions for stabilizing oxidizable compounds
CA2435146C (en) 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
US20050032743A1 (en) * 2002-08-27 2005-02-10 Dusan Miljkovic Compositions and method for steroid homeostasis
US8685438B2 (en) * 2004-03-17 2014-04-01 The Iams Company Compositions, kits, and methods utilizing an added boron source
CN101232821B (zh) * 2005-06-02 2013-01-23 美国硼砂公司 动物和人的骨软骨病的预防和治疗
NZ578133A (en) * 2006-12-06 2012-08-31 Tera Corp B Animal feed compositions comprising supplemental boron and supplemental vitamin c
US8809284B2 (en) 2009-04-03 2014-08-19 Vdf Futureceuticals, Inc. Compositions and methods related to calcitriol
WO2012038985A2 (en) * 2010-09-23 2012-03-29 Tata Global Beverages Limited Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same
US9327025B2 (en) * 2012-10-11 2016-05-03 Hanif Kazerooni Enriched 10-boron composition for cancer therapy and a method of synthesizing the same
JP6438689B2 (ja) * 2014-06-26 2018-12-19 雪印種苗株式会社 ホウ素供給用組成物
US20240325418A1 (en) 2021-10-24 2024-10-03 P.L. Thomas & Co., Inc. Borate complexes of chlorogenic acid and uses thereof
CN117466966A (zh) * 2023-10-31 2024-01-30 南通励成生物工程有限公司 一种果糖硼酸钙的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554020A (en) * 1984-03-29 1985-11-19 W. R. Grace & Co. Hydraulic cement admixture compositions
US4849220A (en) * 1988-04-20 1989-07-18 The United States Of America As Represented By The Secretary Of Agriculture Use of boron supplements to increase in vivo production of hydroxylated steroids
US5312816A (en) * 1991-09-13 1994-05-17 Boron Biologicals, Inc. Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds
US5659027A (en) * 1989-12-20 1997-08-19 University Of North Carolina Boronated compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821196A (en) * 1972-05-23 1974-06-28 Us Agriculture Carbohydrate-boron alkoxide compounds
JP2002514170A (ja) * 1996-07-30 2002-05-14 エナージェティクス,インコーポレイティド 食品補充物
US5985842A (en) * 1998-05-14 1999-11-16 Miljkovic; Dusan Boron compounds/complexes to control hair growth, and methods of use
US6080425A (en) * 1998-05-26 2000-06-27 Topgene, Inc. Boron compounds and complexes as skin-rejuvenating agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554020A (en) * 1984-03-29 1985-11-19 W. R. Grace & Co. Hydraulic cement admixture compositions
US4849220A (en) * 1988-04-20 1989-07-18 The United States Of America As Represented By The Secretary Of Agriculture Use of boron supplements to increase in vivo production of hydroxylated steroids
US5659027A (en) * 1989-12-20 1997-08-19 University Of North Carolina Boronated compounds
US5312816A (en) * 1991-09-13 1994-05-17 Boron Biologicals, Inc. Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1001788A4 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005509661A (ja) * 2001-11-20 2005-04-14 ザ プロクター アンド ギャンブル カンパニー 規定のホウ素化合物を含む組成物及びキット、それらの調製方法、並びにそれらの使用及び投与
LU92551B1 (fr) * 2014-08-29 2016-03-01 Vdf Futureceuticals Inc Compositions et procédés améliorés pour complexes de borocarbohydrate
EP2990058A1 (en) 2014-08-29 2016-03-02 VDF Futureceuticals, Inc. Improved compositions and methods for fructoborate complexes
KR20170095803A (ko) * 2014-08-29 2017-08-23 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
EP3210628A1 (en) * 2014-08-29 2017-08-30 VDF Futureceuticals, Inc. Improved compositions and methods for fructoborate complexes
CN107207536A (zh) * 2014-08-29 2017-09-26 Vdf未来制剂股份有限公司 用于硼碳水化合物复合物的改善的组合物和方法
KR20180089580A (ko) * 2014-08-29 2018-08-08 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
KR101887546B1 (ko) * 2014-08-29 2018-08-10 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
KR102012293B1 (ko) * 2014-08-29 2019-08-20 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
KR20190102079A (ko) * 2014-08-29 2019-09-02 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
KR102209337B1 (ko) 2014-08-29 2021-01-28 브이디에프 퓨쳐슈티컬스, 인코포레이티드 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법
US11160819B2 (en) 2014-08-29 2021-11-02 Vdf Futureceuticals, Inc. Compositions and methods for borocarbohydrate complexes
CN107207536B (zh) * 2014-08-29 2022-03-01 Vdf未来制剂股份有限公司 用于硼碳水化合物复合物的改善的组合物和方法

Also Published As

Publication number Publication date
AU6780098A (en) 1998-10-22
DE69811508D1 (de) 2003-03-27
ES2191291T3 (es) 2003-09-01
EP1001788A4 (en) 2000-11-29
US5962049A (en) 1999-10-05
JP2001518882A (ja) 2001-10-16
EP1001788A1 (en) 2000-05-24
DE69811508T2 (de) 2003-12-11
EP1001788B1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
EP1001788B1 (en) Boron carbohydrate complexes and uses thereof
EP2156751B1 (en) Novel sweetener having sugar-like taste and production method and use of the same
JP5715046B2 (ja) 目的とするヘキソースを所定量含む原料糖とは異なる糖組成の糖組成物の製造方法および製造された糖組成物の用途
EP1112693B1 (en) Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
RU2156087C1 (ru) Биологически активная добавка
KR101007790B1 (ko) 트레할로오스 또는 말티톨과 금속 이온 화합물과의 회합물(會合物)
EP2992887B1 (en) Agent for accelerating the energy expenditure and/or for improving the diminished energy expenditure functionality
EP2754444B1 (en) Composition for improving in vivo metabolism parameter
JPWO1997047209A1 (ja) 脂質代謝改善剤
KR0156539B1 (ko) 4지-o-알파-디이-글루코피라노실 루틴 및 그 제조 방법
CS195704B2 (en) Method of making the diet food mixture
WO2006003107A1 (de) Verwendung von äpfelsäureglucosiden als geschmacksstoffe
JPH06500552A (ja) カルシウム及び微量ミネラル補給品
JP2983503B2 (ja) 高い生物学的利用能をもつ鉄‐カルシウムミネラル補給物
KR20120091398A (ko) 콜라겐 산생 증강제와 그 제조 방법 및 용도
KR19990076491A (ko) 글리코실-엘-아스코르브산의 아실화 유도체
JP2002338473A (ja) 抗疲労組成物
EP3569070A1 (en) Capsule containing pyrroloquinoline quinone or salt thereof and branched chain amino acid
AU2002358347B2 (en) Modified methionine rich food products and process for their manufacture
JPH1128069A (ja) 栄養補給飲食品
CA2431883A1 (en) Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof
US11970435B2 (en) Taste-modified creatine salts, compounds, compositions and uses thereof
RU2183408C1 (ru) Конфета
JP7287677B2 (ja) 経口組成物及び飲食品のミネラル強化剤
KR102405534B1 (ko) 초정수압 처리에 의한 생선의 리페이즈 억제 및 비린내 억제 방법

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 541827

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998913189

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998913189

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998913189

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1998913189

Country of ref document: EP